Bio-Techne (TECH) Insider Trading & Ownership $78.71 -0.04 (-0.05%) As of 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Bio-Techne (NASDAQ:TECH) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.90%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$800,592.00 Get TECH Insider Trade Alerts Want to know when executives and insiders are buying or selling Bio-Techne stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TECH Insider Buying and Selling by Quarter Bio-Techne Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/7/2024Roeland NusseDirectorSell10,400$76.98$800,592.00 (Data available from 1/1/2013 forward) TECH Insider Trading Activity - Frequently Asked Questions Who is on Bio-Techne's Insider Roster? The list of insiders at Bio-Techne includes Brenda S Furlow, Charles R Kummeth, John L Higgins, Robert V Baumgartner, and Roeland Nusse. Learn more on insiders at TECH. What percentage of Bio-Techne stock is owned by insiders? 3.90% of Bio-Techne stock is owned by insiders. Learn more on TECH's insider holdings. Which Bio-Techne insiders have been selling company stock? The following insiders have sold TECH shares in the last 24 months: Charles R Kummeth ($7,068,800.00), and Roeland Nusse ($1,518,572.48). How much insider selling is happening at Bio-Techne? Insiders have sold a total of 99,339 Bio-Techne shares in the last 24 months for a total of $8,587,372.48 sold. Bio-Techne Key ExecutivesMr. Kim Kelderman (Age 56)CEO, President & Director Compensation: $845.71kMr. James T. Hippel (Age 53)Executive VP of Finance & CFO Compensation: $691.78kMr. Shane Bohnen (Age 49)Senior VP, General Counsel & Corporate Secretary Compensation: $353.6kMr. Charles R. Kummeth (Age 64)Senior Advisor & Director Compensation: $1.26MMr. William A. Geist (Age 54)President of Protein Sciences Segment Compensation: $533.67kDr. Gary J. Latham Ph.D.VP & CTODavid ClairSenior Director of Investor Relations & Corporate DevelopmentMr. Gerry AndrosVice President of Sales and MarketingMr. Robert M. Gavin (Age 56)Vice President of Corporate Development Compensation: $724.51kMr. Luca CicchettiManaging Director More Insider Trading Tools from MarketBeat Related Companies Agilent Technologies Insider Ownership Mettler-Toledo International Insider Ownership Waters Insider Ownership Illumina Insider Ownership Bio-Rad Laboratories Insider Ownership Bruker Insider Ownership Charles River Laboratories International Insider Ownership Pacific Biosciences of California Insider Ownership Harvard Bioscience Insider Ownership Thermo Fisher Scientific Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:TECH) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTexas embraces new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | Sponsored"Elon Musk’s Final Move”: Get in NOWI believe Elon's next venture, his "Final Move," could mint more millionaires than any project he's ever been ...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementUnder-the-Radar Crypto Could Soar Under Trump Investors in the know could bank HUGE profits! Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Techne Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Techne With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
